NEWRON PHARMACEUT. EO-20 (XETRA:NP5) — Stock Price

NEWRON PHARMACEUT. EO-20 (XETRA:NP5) is currently trading at €13.15 EUR, up 0.77% today. Over the past 52 weeks, shares have ranged between €7.16 and €32.55. This page tracks NEWRON PHARMACEUT. EO-20's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see NP5 market cap.

NEWRON PHARMACEUT. EO-20 (NP5) Stock Price Chart — Daily History & Trading Volume

The chart below tracks NEWRON PHARMACEUT. EO-20's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.

NEWRON PHARMACEUT. EO-20 Income Statement — Revenue, Profit & Earnings by Year

NEWRON PHARMACEUT. EO-20's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

NEWRON PHARMACEUT. EO-20 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes NEWRON PHARMACEUT. EO-20's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

NEWRON PHARMACEUT. EO-20 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how NEWRON PHARMACEUT. EO-20 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

NEWRON PHARMACEUT. EO-20 Earnings History — EPS Actual vs. Analyst Estimates

Track NEWRON PHARMACEUT. EO-20's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.